Assessing direct costs of treating metastatic triple-negative breast cancer in the USA

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial

(2019) Peter Schmid et al.   LANCET ONCOLOGY

A Review of Triple-Negative Breast Cancer

(2017) Roohi Ismail-Khan et al.   Cancer Control

Real-World Analysis of Medical Costs and Healthcare Resource Utilization in Elderly Women with HR+/HER2− Metastatic Breast Cancer Receiving Everolimus-Based Therapy or Chemotherapy

(2016) Yanni Hao et al.   ADVANCES IN THERAPY

Clinical and economic outcomes by first-line treatment among women with HR+/HER2– metastatic breast cancer in a large US health plan database

(2016) Tanya Burton et al.   CURRENT MEDICAL RESEARCH AND OPINION

ReCAP: Treatment Patterns and Cost of Care Associated With Initial Therapy Among Patients Diagnosed With Operable Early-Stage Human Epidermal Growth Factor Receptor 2-Overexpressed Breast Cancer in the United States: A Real-World Retrospective Study

(2016) Stacey DaCosta Byfield et al.   Journal of Oncology Practice

Long-Term Financial Burden of Breast Cancer: Experiences of a Diverse Cohort of Survivors Identified Through Population-Based Registries

(2014) Reshma Jagsi et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network

(2012) Nancy U. Lin et al.   CANCER

Patient survival and healthcare utilization costs after diagnosis of triple-negative breast cancer in a United States managed care cancer registry

(2012) Onur Baser et al.   CURRENT MEDICAL RESEARCH AND OPINION

Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality

(2011) Montserrat Vera-Llonch et al.   BMC CANCER

Out of pocket cost comparison between Caucasian and minority breast cancer survivors in the Breast Cancer Education Intervention (BCEI)

(2010) Maria Pisu et al.   BREAST CANCER RESEARCH AND TREATMENT

Overall Survival and Post-Progression Survival in Advanced Breast Cancer: A Review of Recent Randomized Clinical Trials

(2010) Everardo D. Saad et al.   JOURNAL OF CLINICAL ONCOLOGY

Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design

(2009) Farrah Kassam et al.   Clinical Breast Cancer